David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 9,930 shares at $28.70 ($285K) on 2025-01-13, disclosed to the SEC on 2025-01-14.
Seasonal sale ($285k) by General Counsel — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.70 | 4,965 | $142K | 50.0% |
| 2 | $28.70 | 4,965 | $142K | 50.0% |
| Total | $28.70 avg | 9,930 | $285K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |